- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
市场最近连续上涨中，短期小心回调。
- 中期趋势：
-
- 长期趋势：
- 波段诊断：
-
技术面诊股
诊断结果：2.4技术面打败了12%的股票
技术面评分前10的股票
近期的平均成本为9.25元，股价在成本下方运行。
平均成本
近期的平均成本为9.25元，股价在成本下方运行。
[{"text":"\u5e73\u5747\u6210\u672c","value":"9.25","date":1660725761,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势跑输大盘，跑输行业平均水平。
[{"date":"2022.08.18","stock":"-1.92","trade":"-0.82","ind":"-0.46"},{"date":"2022.08.17","stock":"0.97","trade":"0.13","ind":"0.45"},{"date":"2022.08.16","stock":"-0.54","trade":"-0.18","ind":"0.05"},{"date":"2022.08.15","stock":"-3.12","trade":"-0.40","ind":"-0.02"},{"date":"2022.08.12","stock":"-4.84","trade":"0.13","ind":"-0.15"},{"date":"2022.08.11","stock":"-0.59","trade":"1.47","ind":"1.60"},{"date":"2022.08.10","stock":"-1.45","trade":"-0.42","ind":"-0.54"},{"date":"2022.08.09","stock":"-10.79","trade":"-0.88","ind":"0.32"},{"date":"2022.08.08","stock":"6.43","trade":"1.90","ind":"0.31"},{"date":"2022.08.05","stock":"33.33","trade":"1.96","ind":"1.19"},{"date":"2022.08.04","stock":false,"trade":"1.76","ind":"0.80"},{"date":"2022.08.03","stock":false,"trade":"-0.21","ind":"-0.71"},{"date":"2022.08.02","stock":false,"trade":"-4.57","ind":"-2.26"},{"date":"2022.08.01","stock":false,"trade":"-0.32","ind":"0.21"},{"date":"2022.07.29","stock":false,"trade":"-1.64","ind":"-0.89"},{"date":"2022.07.28","stock":false,"trade":"-0.33","ind":"0.21"},{"date":"2022.07.27","stock":false,"trade":"0.58","ind":"-0.05"},{"date":"2022.07.26","stock":false,"trade":"-0.11","ind":"0.83"},{"date":"2022.07.25","stock":false,"trade":"0.58","ind":"-0.60"},{"date":"2022.07.22","stock":false,"trade":"-1.17","ind":"-0.06"},{"date":"2022.07.21","stock":false,"trade":"-0.41","ind":"-0.99"}]
盟科药业,上证指数,化学制药指数
压力支撑
该股压力位为9.27元，支撑位为9.12元。
[{"text":"\u538b\u529b\u4f4d","value":"9.27","date":1660752000,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"9.12","date":1660752000,"color":"0x0b52a1"}]
多空趋势
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：2.5资金面打败了13%的股票
主力控盘前10的股票
行业资金
化学制药行业， 近5日资金总体呈流出状态，请投资者谨慎关注该行业的个股。
更新时间：08月19日 08:06
| 机构今日流向(万元) | -1146.34 | 机构5日流向(万元) | -3207.01 |
| 机构10日流向(万元) | -4300.45 | 机构20日流向(万元) | -11982.20 |
消息面诊股
诊断结果：3.3消息面打败了4%的股票
今日有利好新闻的公司
近期该股利空消息较多，投资时需谨慎。
更多>>个股资讯
- 盟科药业：8月18日融券卖出金额43.83万元，占
2022-08-19 - 盟科药业：8月17日获融资买入341.37万元，占
2022-08-18 - 盟科药业：8月16日融券卖出金额197.29万元，
2022-08-17 - 消费：可选消费周报——周专题：并购王者亿滋国际
2022-08-16 - 盟科药业：公司的MRX-18项目为蛋白酶抑制剂，当
2022-08-16 - 盟科药业：8月15日融券卖出金额98.32万元，占
2022-08-16 - 【中航证券医药】行业周报 | 中报业绩已披露数据好
2022-08-15 - 盟科药业：8月12日融券卖出金额84.18万元，占
2022-08-13 - A股“中考成绩”出炉：中国移动跻身“盈利王”
2022-08-12 - 盟科药业：我们公司的康替唑胺片为一款抗菌药产品，对
2022-08-12
消息列表
| 重大利空 | 业绩预告 | 预计增亏 | 2022-07-19 |
| 一般消息 | 募资投向 | 2022-07-18 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 0条 | 0条 | 0条 |
| 利空 | 1条 | 1条 | 0条 |
行业面诊股
诊断结果：3.2行业面打败了12%的股票
化学制药行业最新资金流向
近10日来该行业走势不明显，接近大盘。
行业走势
近10日来该行业走势不明显，接近大盘。
[{"date":"2022.08.18","price":"-0.46","value":"-0.82"},{"date":"2022.08.17","price":"0.45","value":"0.13"},{"date":"2022.08.16","price":"0.05","value":"-0.18"},{"date":"2022.08.15","price":"-0.02","value":"-0.40"},{"date":"2022.08.12","price":"-0.15","value":"0.13"},{"date":"2022.08.11","price":"1.60","value":"1.47"},{"date":"2022.08.10","price":"-0.54","value":"-0.42"},{"date":"2022.08.09","price":"0.32","value":"-0.88"},{"date":"2022.08.08","price":"0.31","value":"1.90"},{"date":"2022.08.05","price":"1.19","value":"1.96"},{"date":"2022.08.04","price":"0.80","value":"1.76"},{"date":"2022.08.03","price":"-0.71","value":"-0.21"},{"date":"2022.08.02","price":"-2.26","value":"-4.57"},{"date":"2022.08.01","price":"0.21","value":"-0.32"},{"date":"2022.07.29","price":"-0.89","value":"-1.64"},{"date":"2022.07.28","price":"0.21","value":"-0.33"},{"date":"2022.07.27","price":"-0.05","value":"0.58"},{"date":"2022.07.26","price":"0.83","value":"-0.11"},{"date":"2022.07.25","price":"-0.60","value":"0.58"},{"date":"2022.07.22","price":"-0.06","value":"-1.17"},{"date":"2022.07.21","price":"-0.99","value":"-0.41"}]
上证指数,化学制药行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | *ST必康 | 37.57% | 22.79% | 5.9分 |
| 2 | *ST辅仁 | 33.33% | -4.88% | 3.9分 |
| 3 | 海思科 | 26.09% | 20.74% | 6.1分 |
| 4 | 华仁药业 | 23.80% | -2.78% | 4.1分 |
| 5 | 恩华药业 | 19.47% | 9.76% | 6.1分 |
| 6 | 迪哲医药 | 16.51% | 2.48% | 4.6分 |
| 8 | 九典制药 | 14.55% | -2.87% | 5.7分 |
| 10 | 人福医药 | 11.53% | -0.14% | 6.2分 |
| 12 | 向日葵 | 9.35% | 11.51% | 5.6分 |
| 14 | 中关村 | 7.92% | 6.49% | 5.5分 |
| 16 | 华特达因 | 7.31% | 5.45% | 5.5分 |
| 18 | 荣昌生物 | 6.80% | -4.49% | 4.4分 |
| 20 | 富士莱 | 4.67% | -1.32% | 4.4分 |
| 22 | 华海药业 | 3.86% | -1.53% | 5.5分 |
| 24 | 广济药业 | 3.35% | 0.27% | 4.2分 |
| 26 | 誉衡药业 | 3.19% | -1.15% | 4.5分 |
| 28 | 艾力斯 | 3.07% | -1.57% | 4.9分 |
| 30 | 吉贝尔 | 2.90% | -1.08% | 5.0分 |
| 32 | 苑东生物 | 2.04% | 0.50% | 5.4分 |
| 34 | 华纳药厂 | 1.79% | -3.08% | 5.1分 |
| 36 | 卫信康 | 1.62% | 1.15% | 6.5分 |
| 38 | 东亚药业 | 1.29% | -0.75% | 4.8分 |
| 40 | 河化股份 | 1.15% | 1.82% | 5.2分 |
| 42 | 新和成 | 0.47% | 6.30% | 5.1分 |
| 44 | 浙江医药 | 0.07% | 1.89% | 4.8分 |
| 46 | - | 0.00% | -0.29% | 分 |
| 48 | 金陵药业 | -0.40% | 3.57% | 5.6分 |
| 50 | ST天圣 | -0.61% | 1.66% | 4.1分 |
| 52 | 舒泰神 | -0.99% | -2.05% | 4.1分 |
| 54 | 康弘药业 | -1.38% | -0.83% | 4.8分 |
| 56 | 信立泰 | -1.62% | -0.12% | 5.3分 |
| 58 | 亚虹医药 | -1.64% | -1.07% | 4.0分 |
| 60 | 哈药股份 | -1.72% | 0.35% | 5.0分 |
| 62 | 健康元 | -2.29% | -1.86% | 4.8分 |
| 64 | 仟源医药 | -2.35% | -1.12% | 4.5分 |
| 66 | 天宇股份 | -2.37% | -3.18% | 4.5分 |
| 68 | 联环药业 | -2.79% | -2.38% | 4.8分 |
| 70 | 尔康制药 | -3.19% | -1.18% | 3.8分 |
| 72 | 奥赛康 | -3.38% | -0.11% | 4.7分 |
| 74 | 本立科技 | -3.54% | -2.46% | 4.3分 |
| 76 | 常山药业 | -3.82% | -1.14% | 4.4分 |
| 78 | 普洛药业 | -4.13% | -2.34% | 5.0分 |
| 80 | 亿帆医药 | -4.35% | -1.87% | 4.6分 |
| 82 | 复旦张江 | -4.46% | -5.50% | 3.8分 |
| 84 | ST冠福 | -4.62% | 0.00% | 4.7分 |
| 86 | 德展健康 | -4.83% | -0.94% | 4.4分 |
| 88 | 汉商集团 | -5.05% | 6.19% | 5.4分 |
| 90 | 振东制药 | -5.40% | -1.00% | 4.2分 |
| 92 | 莎普爱思 | -5.63% | -1.95% | 4.8分 |
| 94 | 普利制药 | -5.79% | -2.55% | 4.9分 |
| 96 | 司太立 | -5.86% | -1.23% | 5.0分 |
| 98 | 亨迪药业 | -5.98% | -2.42% | 4.0分 |
| 100 | 西点药业 | -6.25% | -4.98% | 3.4分 |
| 102 | 海普瑞 | -6.52% | -1.16% | 5.5分 |
| 104 | 康芝药业 | -6.53% | -1.72% | 3.9分 |
| 106 | 罗欣药业 | -6.79% | -1.11% | 4.4分 |
| 108 | 江苏吴中 | -7.04% | -4.56% | 4.0分 |
| 110 | 贝达药业 | -7.18% | -7.41% | 4.1分 |
| 112 | 哈三联 | -7.66% | -2.96% | 3.7分 |
| 114 | 三圣股份 | -8.03% | -1.62% | 4.2分 |
| 116 | 海辰药业 | -8.19% | -2.11% | 4.0分 |
| 118 | 立方制药 | -8.51% | -0.78% | 5.3分 |
| 120 | 千红制药 | -8.56% | -2.20% | 4.6分 |
| 122 | 前沿生物 | -8.85% | -3.97% | 3.5分 |
| 124 | 海正药业 | -9.88% | -2.84% | 4.5分 |
| 126 | 福元医药 | -10.30% | -3.13% | 4.3分 |
| 128 | 广生堂 | -10.84% | -0.03% | 4.2分 |
| 130 | 华东医药 | -10.96% | -6.62% | 4.5分 |
| 132 | 泰恩康 | -11.85% | -6.47% | 4.0分 |
| 134 | 复星医药 | -12.07% | -0.37% | 4.7分 |
| 136 | 长江健康 | -16.43% | -3.86% | 4.5分 |
| 138 | 翰宇药业 | -20.26% | -3.26% | 3.6分 |
| 140 | 新华制药 | -21.08% | -5.61% | 4.3分 |
| 142 | 华润双鹤 | -25.49% | -3.64% | 4.2分 |
| 144 | 奥翔药业 | -35.63% | -7.36% | 4.2分 |
| 146 | 盟科药业 | - | -9.19% | 3.3分 |
行业评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 暂无相关评级 |
更多>>行业资讯
- 2012-02-17青岛：加快向“世界强港”转型新增万吨级泊位24个
- 2012-02-17江苏港口发展“四稳四进”
- 2012-02-17今年河北省重点打造综合性港口群
- 2012-02-16招商轮船：非公开发行A股股票申请获得中国证券监督管理委员会核准
- 2012-02-16泉州市今年将冲刺“亿吨大港”
- 2012-02-16大连市集装箱运输生产“逆市飘红”
- 2012-02-16江苏港口发展“四稳四进”
- 2012-02-16连云港港：绿色生态大港正向我们走来
- 2012-02-15靖江今年港口建设预投28亿元 完成港口货物吞吐量8000万吨
- 2012-02-15舟山“大港口”建设撬动群岛新区大盘
基本面诊股
[ 截止日期：2022-03-31 ]公司经营
盈利能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 141/211 ， 14/211。
[{"date":"2022-03-31","value":"-12.24","vol":"1.19"},{"date":"2021-12-31","value":"-42.75","vol":"2.85"},{"date":"2021-06-30","value":"-14.80","vol":"3.65"},{"date":"2021-03-31","value":"","vol":"2.15"},{"date":"2020-12-31","value":"-30.32","vol":"3.89"}]
| 2022-03-31 | 2021-12-31 | 2021-06-30 | 2021-03-31 | 2020-12-31 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
-12.24 | -42.75 | -14.80 | - | -30.32 |
| 行业(%) | 1.19 | 2.85 | 3.65 | 2.15 | 3.89 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2022-03-31","value":"85.14","vol":"51.94"},{"date":"2021-12-31","value":"92.45","vol":"53.66"},{"date":"2021-06-30","value":"","vol":"51.83"},{"date":"2021-03-31","value":"","vol":"51.04"},{"date":"2020-12-31","value":"","vol":"52.74"}]
| 2022-03-31 | 2021-12-31 | 2021-06-30 | 2021-03-31 | 2020-12-31 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
85.14 | 92.45 | - | - | - |
| 行业(%) | 51.94 | 53.66 | 51.83 | 51.04 | 52.74 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：数据暂时不全，请后续关注
[{"date":"2022-03-31","value":"","vol":"32.13"},{"date":"2021-12-31","value":"","vol":"1004.24"},{"date":"2021-06-30","value":"","vol":"298.59"},{"date":"2021-03-31","value":"","vol":"256.04"},{"date":"2020-12-31","value":"","vol":"-2.41"}]
| 2022-03-31 | 2021-12-31 | 2021-06-30 | 2021-03-31 | 2020-12-31 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
- | - | - | - | - |
| 行业(%) | 32.13 | 1004.24 | 298.59 | 256.04 | -2.41 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2022-03-31","value":"-44.14","vol":"2.70"},{"date":"2021-12-31","value":"-162.11","vol":"24.85"},{"date":"2021-06-30","value":"","vol":"34.21"},{"date":"2021-03-31","value":"","vol":"112.84"},{"date":"2020-12-31","value":"25.17","vol":"-116.92"}]
| 2022-03-31 | 2021-12-31 | 2021-06-30 | 2021-03-31 | 2020-12-31 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
-44.14 | -162.11 | - | - | 25.17 |
| 行业(%) | 2.70 | 24.85 | 34.21 | 112.84 | -116.92 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：偏弱，与行业平均有较大差距，两项指标的行业排名分别为 137/211 ， 136/211。
[{"date":"2022-03-31","value":"0.02","vol":"0.12"},{"date":"2021-12-31","value":"0.01","vol":"0.52"},{"date":"2021-06-30","value":"","vol":"0.26"},{"date":"2021-03-31","value":"","vol":"0.13"},{"date":"2020-12-31","value":"0.00","vol":"0.53"}]
| 2022-03-31 | 2021-12-31 | 2021-06-30 | 2021-03-31 | 2020-12-31 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.02 | 0.01 | - | - | 0.00 |
| 行业(次) | 0.12 | 0.52 | 0.26 | 0.13 | 0.53 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2022-03-31","value":"0.12","vol":"0.73"},{"date":"2021-12-31","value":"0.07","vol":"3.04"},{"date":"2021-06-30","value":"","vol":"1.50"},{"date":"2021-03-31","value":"","vol":"0.66"},{"date":"2020-12-31","value":"","vol":"2.88"}]
| 2022-03-31 | 2021-12-31 | 2021-06-30 | 2021-03-31 | 2020-12-31 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
0.12 | 0.07 | - | - | - |
| 行业(次) | 0.73 | 3.04 | 1.50 | 0.66 | 2.88 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 137/211 ， 142/211。
[{"date":"2022-06-30","value":"-331.38","vol":"-49.88"},{"date":"2022-03-31","value":"-557.66","vol":"-36755.35"},{"date":"2021-06-30","value":"","vol":"-30.90"},{"date":"2021-03-31","value":"","vol":"-52.13"}]
| 2022-06-30 | 2022-03-31 | 2021-06-30 | 2021-03-31 | |
|---|---|---|---|---|
| 现金流量净额/营业收入 | -331.38 | -557.66 | - | - |
| 行业 | -49.88 | -36755.35 | -30.90 | -52.13 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2022-03-31","value":"0.19","vol":"0.00"},{"date":"2021-12-31","value":"1.67","vol":"2.69"},{"date":"2021-06-30","value":"","vol":"2.58"},{"date":"2021-03-31","value":"1.72","vol":"0.07"},{"date":"2020-12-31","value":"0.46","vol":"2.64"}]
| 2022-03-31 | 2021-12-31 | 2021-06-30 | 2021-03-31 | 2020-12-31 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | 0.19 | 1.67 | - | 1.72 | 0.46 |
| 行业 | 0.00 | 2.69 | 2.58 | 0.07 | 2.64 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 121/211 ， 121/211。
[{"date":"2022-03-31","value":"5.45","vol":"4.85"},{"date":"2021-12-31","value":"5.41","vol":"3.73"},{"date":"2021-06-30","value":"16.49","vol":"3.48"},{"date":"2021-03-31","value":"","vol":"2.93"},{"date":"2020-12-31","value":"19.93","vol":"3.42"}]
| 2022-03-31 | 2021-12-31 | 2021-06-30 | 2021-03-31 | 2020-12-31 | |
|---|---|---|---|---|---|
| 流动比率 |
5.45 | 5.41 | 16.49 | - | 19.93 |
| 行业 | 4.85 | 3.73 | 3.48 | 2.93 | 3.42 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2022-03-31","value":"4.90","vol":"4.19"},{"date":"2021-12-31","value":"5.03","vol":"3.16"},{"date":"2021-06-30","value":"15.36","vol":"2.85"},{"date":"2021-03-31","value":"","vol":"2.40"},{"date":"2020-12-31","value":"19.33","vol":"2.87"}]
| 2022-03-31 | 2021-12-31 | 2021-06-30 | 2021-03-31 | 2020-12-31 | |
|---|---|---|---|---|---|
| 速动比率 |
4.90 | 5.03 | 15.36 | - | 19.33 |
| 行业 | 4.19 | 3.16 | 2.85 | 2.40 | 2.87 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 62/211 ， 71/211。
[{"date":"2022-03-31","value":"33.82","vol":"32.98"},{"date":"2021-12-31","value":"32.41","vol":"33.55"},{"date":"2021-06-30","value":"22.20","vol":"32.75"},{"date":"2021-03-31","value":"","vol":"31.00"},{"date":"2020-12-31","value":"7.28","vol":"34.07"}]
| 2022-03-31 | 2021-12-31 | 2021-06-30 | 2021-03-31 | 2020-12-31 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
33.82 | 32.41 | 22.20 | - | 7.28 |
| 行业(%) | 32.98 | 33.55 | 32.75 | 31.00 | 34.07 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2022-03-31","value":"0.51","vol":"0.75"},{"date":"2021-12-31","value":"0.48","vol":"0.99"},{"date":"2021-06-30","value":"0.29","vol":"0.66"},{"date":"2021-03-31","value":"","vol":"0.63"},{"date":"2020-12-31","value":"0.08","vol":"0.72"}]
| 2022-03-31 | 2021-12-31 | 2021-06-30 | 2021-03-31 | 2020-12-31 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
0.51 | 0.48 | 0.29 | - | 0.08 |
| 行业(%) | 0.75 | 0.99 | 0.66 | 0.63 | 0.72 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构预测
暂时还没有机构预测该股2022年的收益，请投资者后续关注。
[{"date":"2018","yellowRectValue":"-1.50","blueLineValue":"","type":""},{"date":"2019","yellowRectValue":"-1.15","blueLineValue":"","type":""},{"date":"2020","yellowRectValue":"-0.86","blueLineValue":"","type":""},{"date":"2021","yellowRectValue":"-2.26","blueLineValue":"","type":""},{"date":"2022","yellowRectValue":"0.00","blueLineValue":"","type":"YC"}]